1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
Saudi Arabia In-Vitro Diagnostics (IVD) Market (By Technology/Technique, Application, End User), Impact of COVID-19, Size, Share, Major Deals & Key Players Analysis - Forecast to 2027

Saudi Arabia In-Vitro Diagnostics (IVD) Market (By Technology/Technique, Application, End User), Impact of COVID-19, Size, Share, Major Deals & Key Players Analysis - Forecast to 2027

  • July 2021
  • 218 pages
  • ID: 6106853
  • Format: PDF
  • Igate Research

Summary

Table of Contents

Search Inside

Saudi Arabia In-Vitro Diagnostics (IVD) market is predicted to reach US$ 1,242 Million by 2027. Saudi Arabia is the largest IVD market in the GCC region. As in other countries, Saudi Arabia is facing the challenges of fighting with infectious disease including HBV, TB, HCV, COVID-19 and HIV, as well as various chronic disease and cancer. In-vitro diagnostics (IVDs) play an important role in the detection of infectious diseases. In vitro diagnosis refers to the diagnosis of diseases or other condition of the human body through the collection, preparation, and testing of human samples with reagents, instruments, and systems. Due to the upsurge of the geriatric population and the high burden of chronic and infectious diseases, like diabetes, cancer, and COVID-19, the Saudi Arabia IVD market is slated to show significant growth, as these chronic disorders can be diagnosed and monitored using In-vitro diagnostics (IVD) products. Moreover, Saudi Arabia government is taking number of initiatives to improve the healthcare sector in the country. The Saudi Ministry of Health plans an expenditure of approximately SAR 23 Billion on the new initiatives within the industry of healthcare. Saudi Arabia government has set the target of privatizing 295 hospitals by 2030, under the Saudi Vision 2030 Plan. Furthermore, the government seeks to improve the country’s healthcare sector by adopting digital information systems.

Impact of COVID-19 on Saudi Arabia In-Vitro Diagnostics Market

The COVID-19 outbreak has become a global stress test. The COVID–19 disease has infected around 193 Million people worldwide. Globally the death toll has reached 4,137,985 according to the latest statistics from the Worldometers (as of July 22, 2021). In Saudi Arabia, COVID–19 disease has infected around 513,284 people (as of July 22, 2021), and the death toll has reached 8,115. The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 outbreak has created a sense of urgency and panic among people globally. In this scenario, the in-vitro diagnostics forms the crux of increased testing. Manufacturers in the in-vitro diagnostic market are focusing on developing novel technologies for maximum testing within a minimum period. For instance, in April 2021, Sysmex Corporation obtained in vitro diagnostic approval for the manufacturing and marketing of the DetectAmp SARS-CoV-2 RT-PCR Kit, a SARS coronavirus nucleic acid kit that detects the RNA of the novel coronavirus (SARS-CoV-2). The novel coronavirus has accelerated the research and development activities in the in-vitro diagnostics market. Development and production in maximum numbers is the need of the hour. Therefore, quick approvals are proving to be the cherry on the cake for the growth of the in-vitro diagnostic market.

By Technique / Technology - Saudi Arabia In-Vitro Diagnostics (IVD) Market Analysis
• On technique/technology basis, Immunoassay and Clinical Chemistry are the leading segment of the Saudi Arabia IVD market.
• Self-Monitoring of Blood Glucose (SMBG) holds the 3rd spot in the Saudi Arabia IVD market in 2020.
• Molecular Diagnostics is likely to account for double digit share of the Saudi Arabia IVD market by 2027.
• Hematology and Coagulation/Hemostasis segments are competing closely to grab maximum market share of the pie.
• Point of Care Testing (POCT) market segment held least share of the Saudi Arabia IVD market.

By Application - Saudi Arabia In-Vitro Diagnostics (IVD) Market Analysis
• On the basis of application, Infectious diseases and Diabetes are the leading segments of the Saudi Arabia IVD market. Together they contributed over 50% share of the total Saudi Arabia IVD market.
• Oncology application accounted for 3rd highest share of the Saudi Arabia IVD market in 2020, followed by cardiovascular diseases segment.
• Autoimmune Diseases was responsible for single digit share of the Saudi Arabia IVD market in 2020, while Nephrology application segment held least share of the Saudi Arabia IVD market.

By End Users - Saudi Arabia In-Vitro Diagnostics (IVD) Market Analysis
• Government Labs & Hospitals was responsible for lion’s share of the Saudi Arabia IVD market in 2020.
• In 2020, Private Labs & Hospitals contributed nearly a quarter to the overall Saudi Arabia IVD market.
• Saudi Arabia government has set the target of privatizing 295 hospitals by 2030, under the Saudi Vision 2030 Plan.

Saudi Arabia IVD Market - Company Analysis
• In June 2021, Thermo Fisher Scientific announced the launch of a new CE-IVD-marked COVID-19 test, The TaqPath COVID-19.
• In April 2021, Sysmex Corporation obtained IVD approval in Japan for the manufacturing and marketing of the DetectAmp SARS-CoV-2 RT-PCR Kit, a SARS coronavirus nucleic acid kit that detects the RNA of the novel coronavirus (SARS-CoV-2).
• In April 2021, Siemens Healthineers completed the acquisition of Varian Medical Systems, Inc.
• In January 2021, Abbott received CE Mark for two new uses of its Panbio COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 virus: asymptomatic testing and self-swabbing.
• In January 2020, Roche entered into a 15-year, non-exclusive partnership with Illumina to broaden the adoption of distributable next-generation sequencing (NGS) based testing in oncology.

The research report titled “Saudi Arabia In-Vitro Diagnostics (IVD) Market (By Technology/Technique, Application, End User), Impact of COVID-19, Size, Share, Major Deals & Key Players Analysis - Forecast to 2027” provides a comprehensive analysis of the Saudi Arabia In-Vitro Diagnostics (IVD) Market.

This 218 Pages report with 58 Figures and 6 Tables has been analyzed from 9 View Points:
1) Saudi Arabia IVD Market and Forecast (2015 - 2027)
2) Impact of COVID-19 on Saudi Arabia IVD Market
3) Saudi Arabia IVD Market Share and Forecast (2015 - 2027)
4) Saudi Arabia IVD Market & Forecast - By Technology/Technique (2015 - 2027)
5) Saudi Arabia IVD Market & Forecast - By Application (2015 - 2027)
6) Saudi Arabia IVD Market & Forecast - By End User (2015 - 2027)
7) Saudi Arabia IVD Market - Major Deals
8) Saudi Arabia IVD Market - Key Players Analysis (2013 - 2026)
9) Saudi Arabia IVD Industry Drivers & Challenges

By Technique / Technology - Saudi Arabia In-Vitro Diagnostics (IVD) Market and Forecast
1. Immunoassay
2. Clinical Chemistry
3. Hematology
4. Coagulation/Hemostasis
5. Microbiology
6. Molecular Diagnostic
7. Self-Monitoring of Blood Glucose (SMBG)
8. Point of Care Testing (POCT)

By Application - Saudi Arabia In-Vitro Diagnostics (IVD) Market and Forecast
1. Infectious Diseases
2. Cardiovascular Diseases
3. Diabetes
4. Oncology
5. Nephrology
6. Autoimmune Diseases
7. Others

By End User - Saudi Arabia In-Vitro Diagnostics (IVD) Market and Forecast
• Government Labs & Hospitals
• Private Labs & Hospitals
• Others

Saudi Arabia IVD Market - Key Players Analysis
1. Roche
2. Abbott
3. Sysmex Corporation
4. Danaher Corporation
5. Thermo Fischer Scientific
6. Siemens Healthineers
7. Biomerieux

Data Source

The analyst employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Companies Mentioned
1. Roche
2. Abbott
3. Sysmex Corporation
4. Danaher Corporation
5. Thermo Fischer Scientific
6. Siemens Healthineers
7. Biomerieux

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

India In-Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • $ 3250
  • October 2021
  • 114 pages

India In-vitro diagnostics market estimated to be valued at USD USD 1255.18 million in 2020 and is expected to reach approximately USD 1990.99 million in 2026, registering a CAGR of nearly 7.10% during ...

  • India
  • In Vitro Diagnostics
  • Industry analysis
  • Chronic Disease Prevalence
  • Diabetes Prevalence

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on